In a recent comprehensive pan-cancer prognosis review, GJB3 survival analysis indicated that breast invasive carcinoma (BRCA) patients with higher GJB3 levels had a longer overall survival time compared to BRCA patients with lower levels of GJB3 [26]. The gene discussed is GJB3; the disease is cancer.